Application of Prognostic Models Based on Psoas Muscle Index, Stage, Pathological Grade, and Preoperative Carcinoembryonic Antigen Level in Stage II-III Colorectal Cancer Patients Undergoing Adjuvant Chemotherapy

Table 1

Correlation between patients’ clinicopathological characteristics and PMI.

Clinical characteristics		Total no.	PMI		Ratio of low PMI (%)	Odds ratio in PMI
			High	Low
Age	>60 years old	119	64	55	42.01	1.031 (1.001–1.063)	0.045
	≤60 years old	77	58	19	24.68
Gender	Male	109	79	30	27.78	0.225 (0.225–0.735)	0.003
	Female	87	43	44	50.57
Stage	II	75	51	24	32.00	1.361 (0.746–2.485)	0.315
	III	121	71	50	41.32
T stage	T1	1	0	1	100.00	0.823 (0.509–1.329)	0.425
	T2	10	3	7	70.00
	T3	40	30	10	25.00
	T4	145	89	56	38.62
Lymph node	N0	75	51	24	32.00	1.395 (0.980–1.986)	0.064
	N1	64	43	21	32.81
	N2	57	28	29	50.88
Pathological grade	G1	9	7	2	22.22	0.797 (0.414–1.534)	0.497
	G2	154	91	63	40.91
	G3	33	24	9	27.27
CEA	High	73	46	27	36.99	0.998 (0.985–1.101)	0.751
	Normal	123	76	47	38.21
Myelosuppression	Grade III-IV	43	25	18	41.86	1.247 (0.626–2.485)	0.530